Xarelto

Bayer Bill Anderson

Pharma

Bayer CEO Anderson sticking out firm's revitalization scheme

CEO Bill Anderson thinks Bayer has a good thing going and that it will be better served by adopting a wait-and-see approach for now.

Fraiser Kansteiner Aug 4, 2026 10:40am

Bayer cross

Biosimilar competiton takes big bite out of Bayer's Eylea sales

May 12, 2026 10:51am

Bayer

Bayer's pharma division sees one more year of declining sales

Mar 4, 2026 11:35am

heart stop delay heart stop stoplight red light

NIH stops Xarelto arm of stroke trial due to safety, efficacy

Feb 10, 2026 4:04pm

Bayer

Bayer stays positive on newer meds as pharma sales stagnate

Nov 12, 2025 11:46am

Bayer Bill Anderson

Bayer has laid off over 12K during Bill Anderson's tenure as CEO

Aug 6, 2025 11:37am